SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

OBIO

Orchestra BioMed Holdings, Inc.
NASDAQHealth Care

Latest close: 5.45 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 1, 2026Reported sale · Form 4Darren Sherman, See Remarks · $95.4KOpen the filing ↗
  2. Oct 1, 2026Notice of sale · Form 144Sherman Darren · Officer, Director · $94.1KOpen the filing ↗
  3. Oct 1, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record39020 flagged findings
Reported transactions (Form 4)80since Apr 12, 2023 · and 19 other holdings
Corporate events (8-K)27since Aug 7, 2020

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Identity

Formerly traded as HSAQ.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-12share offering or dilution eventrecentOpen filing ↗
    “…in which such shares are no longer subject to forfeiture. Pre-funded warrants (see Note 9 – “Warrants” ) are considered outstanding…”
    +1 more passage from the same document
    • “…with the sale of the Royalty Interest, and pursuant to the terms of the Royalty Purchase Agreement, on August 4, 2025, the…”
  • 2026-05-12capital return (buybacks/dividends)recentOpen filing ↗
    “…convertible stock. Liability classification is required for freestanding financial instruments that are (1) subject to an…”
  • 2026-05-12merger or acquisition eventrecentOpen filing ↗
    “…Earnout Consideration, in the event that, during the Earnout Period, the Final Milestone Event occurs. Approximately 91 % of…”
  • 2026-03-12share offering or dilution eventrecentOpen filing ↗
    “…​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Accumulated ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Additional ​ Other ​ ​ ​ ​ Total ​ ​…”
    +1 more passage from the same document
    • “…and (ii) on August 28, 2025, the Company sold an additional 132,282 shares of Company Common Stock, in each case, at a price of $…”
  • 2026-03-12listing compliance noticerecentOpen filing ↗
    “…event of a delisting, we can provide no assurance that any action taken by us to restore compliance with listing requirements would…”
    +1 more passage from the same document
    • “…a stockholder wishes to do so. In the event of a delisting, we can provide no assurance that any action taken by us to restore…”
  • 2026-03-12export control restrictionsrecentOpen filing ↗
    “…by trade conflicts and other geopolitical events. Geopolitical risks and other global events could negatively affect our ability to…”
  • 2026-03-12capital return (buybacks/dividends)recentOpen filing ↗
    “…convertible stock. Liability classification is required for freestanding financial instruments that are (1) subject to an…”
  • 2026-03-12regulatory investigationrecentOpen filing ↗
    “…new intended uses or modifications to existing products; • withdrawals or suspensions of our current PMA or foreign regulatory…”

3 older entries not shown

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 390)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

390 filings on record, the oldest from Jul 17, 20.

Listing the 25 most recent filings of the 390 on record.

8-Ks, explained

Stress2Structure16Governance9
  • Feb 13, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Structure3 material agreements entered2025show all 3hide
    • Oct 28, 25StructureEntered a material agreement+5 more in the same filing8-K 1.01 ↗
    • Aug 4, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Jul 31, 25StructureEntered a material agreement+5 more in the same filing8-K 1.01 ↗
  • Governance3 senior executive changes2024 – 2025show all 3hide
    • Feb 25, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Feb 5, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jul 30, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Nov 28, 23StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jun 8, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jan 31, 23StructureEntered a material agreement+12 more in the same filing8-K 1.01 ↗
  • Jan 25, 23GovernanceA senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
  • Jan 24, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Oct 21, 22StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jul 5, 22StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Feb 10, 22StressPast accounts declared unreliable and being restated8-K 4.02 ↗
  • Aug 7, 20StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • RTW Investments, LP19.2%Apr 27, 26SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Medtronic plc17.8%Dec 31, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Perceptive Advisors LLC10.0%Sep 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Dana Lorenzo5.5%Nov 15, 25SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • BlackRock, Inc.3.7%Mar 31, 25SCHEDULE 13G/A ↗

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Oct 1, Sherman Darren filed notice of intent to sell up to $94K. That is about 0.02% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $95K on Oct 1, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+3 more recent notices · 3 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Oct 1, 26Sell$95KDarren ShermanSee Remarks↗
  • Sep 3, 26Buy$48KDavid P HochmanSee Remarks↗
  • Sep 1, 26Sell$74KDarren ShermanSee Remarks↗
  • Aug 26, 26Buy$11KDarren ShermanSee Remarks↗
  • Aug 3, 26Sell$61KDarren ShermanSee Remarks↗
  • Jul 1, 26Sell$64KDarren ShermanSee Remarks↗
  • Jun 1, 26Sell$58KDarren ShermanSee Remarks↗
  • Jun 1, 26Buy$19KDavid P HochmanSee Remarks↗
  • May 18, 26Buy$2KJason Aryeh↗
  • May 15, 26Buy$19KDavid P HochmanSee Remarks↗
  • May 15, 26Buy$35KJason Aryeh↗
  • May 14, 26Buy$83KEric S Fain↗

There are 2 more transactions in this stretch.

Stock compensation, tax and giftsshow the 26 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 10, 26Tax$19KDavid P HochmanSee Remarks↗
  • Sep 10, 26Tax$19KDavid P HochmanSee Remarks↗
  • Aug 26, 26Tax$1KJoshua AielloPrincipal Accounting Officer↗
  • Aug 26, 26Tax$26KDarren ShermanSee Remarks↗
  • Aug 26, 26Tax$16KAndrew Lawrence TaylorChief Financial Officer↗
  • Aug 12, 26Tax$19KChris Cleary↗
  • Aug 12, 26Tax$22KJohn Prosper Mack↗
  • Aug 12, 26Tax$23KEric S Fain↗
  • Aug 12, 26Tax$17KDavid Pacitti↗
  • Jun 24, 26Taxamount n/aJohn Prosper Mack↗
  • Jun 24, 26Taxamount n/aChris Cleary↗
  • Jun 24, 26Taxamount n/aDavid Pacitti↗
  • Jun 24, 26Taxamount n/aEric S Fain↗
  • Jun 23, 26Compensationamount n/aJohn Prosper Mack↗
  • Jun 23, 26Compensationamount n/aPamela Ann Connealy↗
  • Jun 23, 26Compensationamount n/aDavid Pacitti↗
  • Jun 23, 26Compensationamount n/aEric S Fain↗
  • Jun 10, 26Tax$13KDavid P HochmanSee Remarks↗
  • Jun 10, 26Tax$146KAndrew Lawrence TaylorChief Financial Officer↗
  • May 28, 26Tax$20KDarren ShermanSee Remarks↗
  • May 28, 26Tax$12KAndrew Lawrence TaylorChief Financial Officer↗
  • Apr 27, 26Other$125RTW INVESTMENTS, LP↗
  • Mar 25, 26Tax$148KDavid P HochmanSee Remarks↗
  • Mar 25, 26Tax$1KJoshua AielloPrincipal Accounting Officer↗
  • Mar 25, 26Tax$152KDarren ShermanSee Remarks↗
  • Feb 12, 26Compensationamount n/aDavid P HochmanSee Remarks↗

The full record holds 181 transactions and goes back to Jan 24, 23.

Its sector and its market

Orchestra BioMed Holdings, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Orchestra BioMed Holdings, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Orchestra BioMed Holdings, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
390 documents on file, from Jul 17, 2020 to Oct 2, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.